Global Peripheral Artery Disease Market Research Report—Forecast till 2025

Global Peripheral Artery Disease Market Research Report—Forecast till 2025

Market Synopsis
The Global Peripheral Artery Disease Market is accounted to register a CAGR of 4.84% to reach USD 23,624.01 Million during the forecast period. The disorder of blood vessels located outside the brain and heart is known as a peripheral artery. The reasons PAD are occurs when plaque builds up in the arteries that carry blood to the head, organs, and limb because of fat, cholesterol, calcium, fibrous tissue, and other substances in the blood. The growing geriatric population and increasing prevalence of peripheral artery disorder with rising product approvals are driving the market growth. Additionally, the increasing prevalence of diabetes is also expected to drive the global market.
The global peripheral artery disease market is estimated to reach a steady growth during the forecast period owing to focusing on product launches, approvals, and partnerships to gain market dominance and keep their product updated and in demand. However, the global market growth product recalls and failures are expected to restrain market growth.

Market Segmentation
The Global Peripheral Artery Disease Market has been categorized based on Treatment Type and End User. By treatment type, the global market has been segregated into devices and drugs. Devices are further classified into angioplasty balloon, angioplasty stents (stenting), catheters, plaque modification devices (atherectomy), hemodynamic flow alteration devices, and others. Drugs are further sub-divided into lipid-lowering drugs, blood pressure-lowering drugs, glucose regulating drugs, and blood clot preventing drugs. The global peripheral artery disease market, by the end-user, has been categorized as hospitals and clinics, ambulatory surgery centers, and others.
Regional Analysis
The geographical analysis of the global peripheral artery disease market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The Americas were likely to drive the largest market of the global peripheral artery disease market the region was contributed to the largest market share in 2018. The regional market growth is attributed to the growing prevalence of diabetes, increasing healthcare expenditure, and rising cases of obesity. However, the adoption of modern lifestyle like dietary habits, alcohol consumption, lack of physical activities are inclining individuals to peripheral artery disease and is driving the market growth.
Europe is accounted for the second-largest market for peripheral artery disease with Western Europe, holding the largest market share. The European market is expected to register a significant growth rate during the forecast period owing to rising cardiovascular diseases and increasing cigarette smoking population. Moreover, the rising geriatric population in the European Union is propelling the growth of the peripheral artery disease market in Europe.
Asia-Pacific is expected to anticipate the highest market growth potential over the forecast period owing to the growing patient pool and increasing technological advancements.

Major Players
The Major Players in the Global Peripheral Artery Disease Market are Koninklijke Philips NV (Netherlands), B. Braun Melsungen AG (Germany), Cook (US), Medtronic (Ireland), Bayer AG (Germany), Boston Scientific Corporation (US), Becton, Dickinson, and Company (BD) (US), Terumo Medical Corporation (Japan ), Biotronik (Germany), Cardinal Health (US), and others.

COVID 19 Impacts
We are continuously tracking the impact of COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations and many other useful insights.

Frequently Asked Questions